Family History
441 articles
Keeping My Promise Led to an Earlier Diagnosis
Yolanda L. Jackson promised her doctor she would get a CT scan of her digestive tract. This led to an early diagnosis of pancreatic cancer.
The Positive Impact of a Pancreatic Cancer Clinical Trial
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.
Diagnosing Pancreatic Cancer: Tests to Expect
What can you expect during pancreatic cancer diagnostic testing? Dr. Gobind Anand offers expert guidance to stay informed throughout the process.
An Update on the Whipple Procedure
Learn more about the latest developments in the Whipple procedure, the surgery most often used to remove pancreatic tumors.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
High-Dose Vitamin C Targeting KRAS and BRAF in Pancreatic Cancer
Learn how Dr. Manish Shah is leading clinical trials using high-dose Vitamin C to target KRAS and BRAF mutations in pancreatic cancer.
PATHFINDER Blood Test Trial Focused on Early Detection
Dr. Minetta Liu is part of the team conducting a clinical trial to find biomarkers that will become an easy blood test for pancreatic cancer.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Cancer Commons and xCures Hope to Use Real-World Data to Improve Care
Lola Rahib and Patrick van der Valk explain how Cancer Commons and xCures are using real-world data to improve care for future patients.
2022 AACR Annual Meeting Update
The 2022 AACR Annual Meeting featured the latest in pancreatic cancer breakthroughs, research in artificial intelligence, screening, detection, and vaccines.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
Exploring Alternatives to Creon for Pancreatic Enzyme Replacement Therapy
Oncology dietitian Meghan Laszlo explains how pancreatic enzyme replacement drug Creon works and available alternatives.
New Phase III Clinical Trial Actively Recruiting
Dr. Zev Wainberg is enthusiastic about the phase III clinical trial combining a new drug and standard chemo to make immunotherapy more effective.
About Us
Let’s Win is your guide to hope and action. Our mission is to guide patients with vital information for better outcomes. We envision a world where all patients have access to the best treatment options. Let’s Win is a go-to guide with easy-to-understand, medically vetted and actionable content focused on the needs of the patient […]